Canseco R S, Sparks A E, Page R L, Russell C G, Johnson J L, Velander W H, Pearson R E, Drohan W N, Gwazdauskas F C
Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg 24061-0315.
Transgenic Res. 1994 Jan;3(1):20-5. doi: 10.1007/BF01976023.
Litter size of DNA microinjected zygotes is lower than for non-manipulated zygotes. The rate of embryonic and fetal survival in early, mid and late gestation was determined to assess whether DNA integration was responsible for embryonic losses. Also, the effect of including non-microinjected embryos with injected embryos on pregnancy rate and transgenic pup production was determined. In Experiment 1, one-cell embryos from immature CD-1 mice were microinjected with a whey acidic protein promoter-human protein C gene construct. One hour after microinjection embryos were transferred to pseudopregnant recipients (45 transfers of 30 embryos each). Fifteen recipients were sacrificed on day 4, 12 and 18 of gestation and the embryos/fetuses analysed for the transgene. The percentage of embryos or fetuses that were positive for the transgene was not significantly different at any day. However, the number of viable embryos at day 4 was significantly greater than fetuses on days 12 or 18. In addition, a high degree of mosaicism was observed in day 18 fetuses and placentae recovered. In Experiment 2, one-cell embryos from CD-1 mice were microinjected and co-transferred with non-manipulated embryos (C57BL/6). Pregnancy rate and the total number of pups born were improved by addition of non-injected embryos. However, the number of transgenic mice produced was similar whether non-injected embryos were included or not. There were 32.2% (15/46) transgenic pups when 0 non-injected embryos were transferred compared with 15.1% (13/86) transgenic pups when 4 or 8 non-injected embryos were added to the transfers. In summary, a high degree of embryonic and fetal mortality occurs among microinjected embryos.(ABSTRACT TRUNCATED AT 250 WORDS)
DNA显微注射受精卵的产仔数低于未处理的受精卵。测定了妊娠早期、中期和晚期的胚胎及胎儿存活率,以评估DNA整合是否是胚胎损失的原因。此外,还确定了将未显微注射的胚胎与注射过的胚胎一起植入对妊娠率和转基因幼崽产生的影响。在实验1中,将来自未成熟CD-1小鼠的单细胞胚胎显微注射乳清酸性蛋白启动子-人蛋白C基因构建体。显微注射后1小时,将胚胎转移到假孕受体中(每次转移30个胚胎,共45次转移)。在妊娠第4天、12天和18天处死15只受体,并对胚胎/胎儿进行转基因分析。在任何一天,转基因呈阳性的胚胎或胎儿的百分比均无显著差异。然而,第4天的存活胚胎数量显著多于第12天或18天的胎儿。此外,在回收的第18天胎儿和胎盘中观察到高度嵌合现象。在实验2中,对来自CD-1小鼠的单细胞胚胎进行显微注射,并与未处理的胚胎(C57BL/6)共同转移。添加未注射的胚胎可提高妊娠率和出生幼崽的总数。然而,无论是否包括未注射的胚胎,产生的转基因小鼠数量相似。当不转移未注射的胚胎时,转基因幼崽的比例为32.2%(15/46),而当在转移中添加4个或8个未注射的胚胎时,转基因幼崽的比例为15.1%(13/86)。总之,显微注射胚胎中存在高度的胚胎和胎儿死亡率。(摘要截断于250字)